KRAS and lung carcinoma: Aurora A interacts with KRAS G12C-CRAF complex in lung cancer cells, and dual inhibition of G12C and aurora A dissociates the complex resulting in a long-term MAPK signaling inhibition and the prevention of tumor relapse.